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Pseudomonas aeruginosa is 1 of the major agents of noso-
comial infections in burn centers, especially in Iran.1,2 This 
opportunistic and highly resistant bacterium causes severe prob-
lems for hospitalized burn patients.3 Infections of P. aeruginosa, 
particularly multidrug-resistant (MDR) strains, in burn patients 
is commonly discussed as a general complication. These patients 
are obviously at high risk for difficult-to-treat or untreatable 
infections.4 Severely burned patients with immunological 
system defects develop life-threatening infections frequently, 
and as a result, this gram-negative bacterium continues to be a 
general complication in burn-related morbidity and mortality 
worldwide.5-7
Multidrug-resistant bacteria have commonly been reported 
as the cause of nosocomial outbreaks of infection in burn units 
(BU) or as colonizers of the wounds of burn patients. Resis-
tance to many drugs has been reached to a worrying point in 
P. aeruginosa isolated from burn patients in Iran.8-10 Previous 
studies confirmed resistance to many antibiotics used routinely 
for treatment of burn wounds infected by P. aeruginosa in 
Iranian hospitals.2,11,12 For example, Hadadi and colleagues 
have shown P. aeruginosa isolates were resistant to ceftizoxime 
(99%), ceftazidime (59.6%), ticarcilin (50%), ceftriaxone 
(44.3%), and cefoperazone (37.5%).12 In another study, resis-
tances of 75% for imipenem and 39% for ciprofloxacin in P. 
aeruginosa isolated from nosocomial source was reported.11 It 
was shown that P. aeruginosa is the main infectious agent at the 
Tohid Burn Center in Tehran with a frequency of 73.9%, and 
it was revealed that 95% of isolates were resistant to gentami-
cin, carbenicillin, co-trimoxazole, ceftizoxime, and tetracycline, 
90% for amikacin and 82% for ciprofloxacin.2 P. aeruginosa 
has been demonstrated as the leading cause of nosocomial 
infections in Iranian BU.1 Molecular epidemiologic studies 
have a very important role in the determination of transmis-
sion routes of the pathogen for managing infection. This type 
of information can be used in clinical settings to separate 
continuing epidemics of an infectious agent from incidentally 
increased infection rates. DNA typing methods are known as 
the most suitable approaches for epidemiological studies.13,14 
Pulsed-field gel electrophoresis (PFGE) is 1 of the most power-
ful techniques and is used as the gold standard for the typing 
of many microorganisms like P. aeruginosa.15-17 In this study, 
PFGE was applied for molecular typing, and the results were 
used for detailed analysis of the routes of P. aeruginosa coloni-
zation in the BU. Since effective management of nosocomial 
infections, especially in BU, needs to inform about infection 
transmission routes and drug susceptibility of pathogens, this 
study was conducted to investigate antibiotic susceptibility and 
molecular epidemiology of P. aeruginosa isolated in the BU of 
Shahid Motahhari Hospital, 1 of the referral BUs in Tehran, 
Iran, between February 2008 and June 2008.
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Abstract 
Background: Pseudomonas aeruginosa  
is 1 of the major agents of nosocomial 
infections in burn centers. Our objectives 
were to determine the genetic diversity of  
P. aeruginosa isolated from burn patients. 
 
Methods: One hundred thirty-one  
P. aeruginosa isolates were collected from 
the burn center of Shahid Motahhari Hospital 
in Tehran. Phenotypic screening for drug 
susceptibility was performed by disk diffusion 
method according to Clinical Laboratory 
Standards Institute guidelines, and genetic 
diversity of all isolates was determined by 
the pulsed-field gel electrophoresis (PFGE) 
technique.  
 
Results: Antimicrobial susceptibility testing 
showed that the majority of P. aeruginosa 
strains were resistant to ceftizoxime (87%) 
and aztreonam (80.2%). Pulsed-field gel 
electrophoresis revealed 11 profiles in which 
environmental strains were included in 
PFGE1 and PFGE7 patterns. The major PFGE 
profile was PFGE1 containing 18 (42.9%) 
MDR isolates and including an environmental 
MDR bacterium. 
 
Conclusions: Our findings highlighted that 
further attention needs to be focused on the 
disinfection of this burn unit. 
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Materials and Methods
Sampling and Patient Demographics
The intensive care BU of the Shahid Motahhari Hospital is 
a referral center for patients with severe burn injuries. Between 
February 2008 and June 2008, 129 P. aeruginosa isolates from 
burn patients and 2 isolates from the hospital environment were 
collected. Patients hospitalized in the BU had different types 
of burn injuries. They included 14 patients (10%) under 15 
years old and 126 patients (90%) over 15 years old, 108 (77.1%) 
were male, and 32 (22.9%) were female. The clinical samples 
included burn wound swabs, blood, and biopsy specimens, 
and the environmental samples included water from faucets, 
antiseptics, hand-washing solutions and swabs from sinks, hy-
drotherapy equipment, floors, and other damp surfaces with a 
potential for cross-contamination throughout the BU.
Bacterial Analysis
All samples were cultured in Mueller-Hinton agar, and  
P. aeruginosa were isolated from the samples by standard micro-
biology procedures. Each isolate originated from a single colony 
of each patient’s culture and was identified as P. aeruginosa by 
API 20NE (bioMérieux, Lyon, France). Pseudomonas aeruginosa 
isolates were stored in Luria-Bertani broth medium (Merck 
KGaA, Darmstadt, Germany) containing 30% glycerol at -80°C.
 
Drug Susceptibility Testing
Drug susceptibility testing and interpretation were per-
formed according to Clinical Laboratory Standards Institute 
guidelines.18 Tests were completed for all isolates by disk diffu-
sion method for 13 antimicrobial agents, including amikacin, 
aztreonam, cefotaxime, ceftazidime, ceftizoxime, ciprofloxacin, 
gentamicin, imipenem, kanamycin, meropenem, piperacillin, 
piperacillin-tazobactam, and tetracycline (Mast Diagnostics, 
Mast Group, Merseyside, UK). Multidrug resistant P. aerugi-
nosa isolates were resistant to ceftazidime and at least 3 of the 
following antibiotics: amikacin, aztreonam, ciprofloxacin, 
gentamicin, imipenem, piperacillin, and aminoglycosides. 
Pseudomonas aeruginosa ATCC 27853 was used as a control.
PFGE Method
Pulsed-field gel electrophoresis was performed according to 
a previously described protocol by Gautom with some modifica-
tions.16 Briefly, P. aeruginosa bacteria were grown overnight on 
Mueller-Hinton agar plates and then suspended directly with 
sterile cotton swabs in about 2 to 3 mL of TE buffer  
(100 mM Tris and 100 mM EDTA). The cell suspensions were 
adjusted with TE buffer to 20% transmittance by using a Bio-
Rad spectrophotometer (Bio-Rad Laboratories, Hercules, CA). 
Aliquots of 100 µL of the cell suspensions were transferred to 
1.5 mL microcentrifuge tubes. Lysozyme and proteinase K were 
added to a final concentration of 1 mg/mL each and mixed by 
pipetting. The bacterial suspensions were incubated at 37°C 
for 10 to 15 minutes. Multi-purpose (MP) agarose (Roche 
Diagnostics GmbH, Mannheim, Germany) was prepared in 
water to a final concentration of 1.2% and maintained at 55°C 
in a water bath. Following the lysozyme-proteinase K incuba-
tion, 7 µL of 20% sodium dodecyl sulfate and 140 µL of 1.2% 
MP agarose were mixed with each bacterial suspension using a 
pipette. This bacterium-agarose mixture was immediately added 
to plug molds (Pharmacia Biotech, Stockholm, Sweden). The 
plugs were allowed to solidify for 5–10 minutes at 4°C and then 
transferred to 2 mL round-bottom tubes containing 1.5 mL of 
ESP buffer (0.5 M EDTA, pH 9.0; 1% sodium lauryl sarcosine; 
1 mg of proteinase K per mL). These were incubated in a water 
bath at 55°C for 2 hours. After the completion of proteolysis, 
the plugs were transferred to 50 mL tubes containing 8 mL to 
10 mL of sterile, preheated (50°C) distilled water and incubated 
for 10 minutes at 50°C with a gentle mixing in a shaker water 
bath. Subsequently, 4 50°C washes were done in a shaker water 
bath for 15 minutes each with 8 mL to 10 mL of preheated 
(50°C) TE buffer (10 mM Tris, pH 8.0; 1 mM EDTA, pH=8). 
The plugs were then cooled to room temperature in a TE buf-
fer. At this point, they could be used immediately or stored for 
3 to 4 weeks at 4°C in 1 mL of TE. For restriction endonuclease 
digestion, 2 1 mm thick slices of each plug were incubated at 
37°C for 3 hours with 50 U of XbaI enzyme, in 100 mL of the 
appropriate (1×) restriction enzyme buffer.
Multi-purpose agarose at a concentration of 1.2% provided 
the desired resolution of DNA fingerprints. The plug slices of 
the samples were loaded and electrophoresed in 1.2% MP aga-
rose with 2.5 liters of standard 0.5× TBE running buffer. The 
electrophoresis was performed with the Gene Navigator System 
(Pharmacia Biotech). Electrophoresis run conditions were de-
signed for a run time of 24 hours. In these runs, the initial and 
final switch times were 5 seconds and 90 seconds, respectively; 
all other parameters remained identical with those of the stan-
dard procedure.
Following electrophoresis, the gels were stained for  
20 minutes in 500 mL of sterile distilled water containing 
50 µL of ethidium bromide (10 mg/mL) and destained in 3 
washes of 30 minutes each in 1 liter of distilled water. The 
gels were analyzed under UV transilluminator (UVItec, Cam-
bridge, UK), and TIFF files were saved for analyzing with 
GelCompar software (Applied Maths, Sint-Martens-Latem, 
Belgium). Cluster analysis of the Dice similarity indices based 
on the unweighted pair group method using arithmetic aver-
ages (UPGMA) was done to generate a dendrogram describing 
the relationship among pulsotypes. A difference of at least 1 
restriction fragment in the profiles was considered the criterion 
for discriminating between clones. Visual analysis was com-
pleted based on Tenover criteria.19
Results
Drug Susceptibility Testing
Drug susceptibility tests by the disk diffusion method 
showed many isolates were resistant to ceftizoxime (87%), 
aztreonam (80.2%), kanamycin (79.4%), tetracycline (78.6%), 
and ceftazidime (74.8%), but few isolates were resistant to imi-
penem (16%), piperacillin/tazobactam (19.1%), and amikacin 
(35.1%). Forty-two MDR P. aeruginosa isolates were recovered 
from clinical samples, and 1 isolate was recovered from the en-
vironment. The results of the drug susceptibility tests are shown 
in Table 1.
PFGE Fingerprinting
Genotyping by PFGE reveals different profiles (Figure 1) 
that by GelCompar software classified 11 profiles, PFGE1 to 
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resistant to multiple classes of antibiotics; these MDRs were 
resistant to similar classes of drugs. The PFGE1 with 42 isolates 
was the major PFGE group that included 18 MDR clinical sam-
ple isolates and 1 environmental MDR strain. The PFGE2 pro-
file had 23 isolates and 13 MDR isolates, and the PFGE3 profile 
had 17 isolates with 6 MDR strains. Other profiles comprising 
PFGE4, 5, 6, 7, 8, 9, 10, and 11 have 13, 8, 4, 9, 5, 5, 3, and 2 
isolates, respectively. The PFGE1 to PFGE5 profiles included 
MDR isolates (Table 2). Two environmental isolates (E1 and 
E2) were classified in PFGE1 and PFGE7 profiles, respectively. 
It was shown that E1 was an MDR isolate. 
Discussion
Pseudomonas aeruginosa infection is a major cause of 
mortality and morbidity in hospitalized patients of developing 
countries.1 One of the most important aspects for choosing an 
efficient method to prevent this infection is determining the 
relationship between genotype and drug susceptibility. In this 
study, the relationship between isolates, genotypes, and drug 
susceptibility patterns of P. aeruginosa isolates were investi-
gated. The results may be useful for achieving an appropriate 
approach to eliminate infections. Pulsed-field gel electrophore-
sis analysis is 1 of the best genotyping methods for P. aeruginosa 
fingerprinting and is sometimes mentioned as the gold standard 
method for this bacterium.13 We used PFGE for typing all  
P. aeruginosa isolates obtained from hospitalized patients in 
Shahid Motahari BU and environmental isolates. All of the  
P. aeruginosa isolates were typeable, and 11 PFGE profiles were 
identified. These PFGE profiles were analyzed for any possible 
relationship to environmental and/or MDR isolates.
Multidrug-resistant bacteria have commonly been reported 
as the cause of nosocomial outbreaks of infection in BUs or 
as colonizers of the wounds of burn patients.1,11 Pseudomonas 
aeruginosa has been demonstrated to be a leading cause of noso-
comial infections in Iranian burn patients, and antimicrobial 
resistance has reached a critical point.2,8-10 In previous studies, 
resistance to many antibiotics used to treat burn injuries in-
fected by P. aeruginosa in Iranian hospitals were shown.1,2,8-12 
For example in 1 study, resistance of P. aeruginosa isolates to 
ceftizoxime, ceftazidime, ticarcilin, ceftriaxone, and cefopera-
zone were 99%, 59.6%, 50%, 44.3%, and 37.5%, respectively.2 In 
another study, 75% resistance for imipenem and 39% for cipro-
floxacin in P. aeruginosa isolates from a nosocomial source were 
shown.12 In the Tohid Burn Center in Tehran, P. aeruginosa 
Table 1_In Vitro Susceptibilities of 131 P. aeruginosa 
Isolates to 13 Antimicrobial Agents
 No. (%) 
Resistant Intermediate Sensitive Antibiotic
46 (35.1) 8 (6.1) 77 (58.8) Amikacin
105 (80.2) 7 (5.3) 19 (14.5) Aztreonam
66 (50.4) 10 (7.6) 55 (42.0) Cefotaxime
98 (74.8) 1 (0.8) 32 (24.4) Ceftazidime
114 (87.0) 12 (9.2) 5 (3.8) Ceftizoxime
66 (50.4) 15 (11.4) 50 (38.2) Ciprofloxacin
99 (75.6) 2 (1.5) 30 (22.9) Gentamicin
21 (16.0) 19 (14.5) 91 (69.5) Imipenem
104 (79.4) 2 (1.5) 25 (19.1) Kanamycin
48 (36.7) 2 (1.6) 81 (61.8) Meropenem
90 (68.7) 13 (9.9) 28 (21.4) Piperacillin
25 (19.1) 19 (14.5) 87 (66.4) Piperacillin- 
     Tazobactam
103 (78.6) 9 (6.9) 19 (14.5) Tetracycline
Figure 1_XbaI-PFGE profiles of P. aeruginosa strains isolated from burn patients. M; Pulse Marker 0.1–200 kb (Sigma). Lines 5, 6, 7, and 18 
refer to the PFGE1 profile; lines 3, 8, 10, and 11 refer to the PFGE2 profile; lines 4 and 20 refer to the PFGE3 profile; lines 2 and 12 refer to the 
PFGE4 profile; lines 16 and 17 refer to the PFGE5 profile; line 15 refers to the PFGE6 profile; lines 14 and 21 refer to the PFGE7 profile; line 13 
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was the main infectious agent, with a frequency of 73.9, and it 
was revealed that these isolates were resistant more than 95% 
for gentamicin, carbenicillin, co-trimoxazole, ceftizoxime, and 
tetracycline, 90% for amikacin, and 82% for ciprofloxacin.2 
Drug susceptibility tests of P. aeruginosa isolates were 
completed, and some isolates resistant to many antibiotics were 
determined. Forty-three MDR isolates with 5 PFGE profiles 
(PFGE1-PFGE5) were found in this study. These results reveal 
different potential sources for MDR isolates. Our results have 
shown 2 environment sources for FGE1 and PFGE7 profiles, 
which were found in the tap water and sink drains, respectively. 
However, we may have missed some important outsource agents 
for other PFGE patterns in this study. 
In this study some isolates, including the MDR PFGE1 
strains, showed resistance to amikacin, aztreonam, ceftazidime, 
imipenem, meropenem, and piperacillin, which are the first-
line antibiotics used in BU. This may illustrate the importance 
of the selective pressure of antibiotics in the emergence and 
selection of MDR epidemic strains. Nowadays, outbreaks with 
MDR P. aeruginosa strains have become rather frequent, and 
the persistence of MDR P. aeruginosa clones in BUs have been 
reported.10,11
Pseudomonas aeruginosa colonization may originate 
from endogenous sources such as the intestinal tract or from 
exogenous sources such as contaminated equipment or other 
patients with P. aeruginosa. Understanding the routes of colo-
nization is critical to the development of efficient preventive 
measures against infection. Even if the overall rate of P. aerugi-
nosa colonization is not significantly reduced, it is important 
to recognize cross-infecting strains, especially if they exhibit 
resistance to a variety of antibiotics and give rise to severe infec-
tions. Colonized patients represent a continuous reservoir of 
(epidemic) strains from which other patients can be colonized 
via cross-acquisition. In contrast with some studies,3 we isolated 
2 P. aeruginosa strains from the inanimate hospital environ-
ment that were an important source of the patients’ infections. 
The large number of unique genotypes observed in the patients, 
however, suggests that most of the patients were colonized from 
an exogenous source. On the other hand, 42 patients were colo-
nized with the PFGE1 strain, 23 patients were colonized with 
the PFGE2 strain, and 17, 13, 8, 4, 9, 5, 5, 3, and 2 patients 
were colonized with PFGE3 to PFGE11 isolates, respectively. 
There was minimal overlap between the hospitalization periods 
of patients. In addition, a thorough survey of the inanimate 
hospital environment successfully identified 2 ongoing reser-
voirs of PFGE1 and PFGE7 strains found in the tap water and 
sink drains, respectively. 
Several studies have demonstrated that cross acquisition 
can play an important role in the epidemiology of nosocomial 
colonization and infection with P. aeruginosa.14,20-22 Nikbin 
and colleagues have shown that a few isolates were distributed 
widely at 2 hospitals and the environment in Tehran.21 
In this study, the transmission of some patients with 
PFGE1 and PFGE7 profiles may have originated from environ-
mental sources, and other isolates may have originated from the 
staff’s hands, equipment, or other unknown sources in the BU. 
These results emphasize the importance of completing routine 
drug susceptibility tests and molecular fingerprinting to moni-
tor routes of infections and changes in the drug resistance of 
infectious agents for successful management of infections.  
Conclusion
In conclusion, our findings show that environmental 
sources may have a significant role in the transmission of P. 
aeruginosa in this BU. This study highlighted the need for ad-
ditional attention to the disinfection of inanimate objects in the 
hospital environment to limit the transfer of P. aeruginosa in 
this BU. Moreover, the use of some antimicrobial agents must 
be restricted, due to the high resistance to them.  LM
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